KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Shares Outstanding (Diluted Average): 2011

Historic Shares Outstanding (Diluted Average) for Sarepta Therapeutics (SRPT) over the last 1 years, with Dec 2011 value amounting to $129.6 million.

  • Sarepta Therapeutics' Shares Outstanding (Diluted Average) rose 7.54% to $106.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $106.6 million, marking a year-over-year increase of 7.54%. This contributed to the annual value of $129.6 million for FY2011, which is N/A change from last year.
  • According to the latest figures from FY2011, Sarepta Therapeutics' Shares Outstanding (Diluted Average) is $129.6 million.
  • In the past 5 years, Sarepta Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $129.6 million in FY2011 and a low of $129.6 million during FY2011.
  • Moreover, its 1-year median value for Shares Outstanding (Diluted Average) was $129.6 million (2011), whereas its average is $129.6 million.